The U.S. Food and Drug Administration says it is starting a major hiring initiative designed to fill more than 1,300 public health positions.
Biologists, chemists, medical officers, mathematical statisticians and investigators are among the experts with science or medical backgrounds the FDA is seeking.
"It takes a large pool of talented people for the FDA to protect and promote the public health," said John Dyer, the FDA's deputy commissioner for operations and its chief operating officer. "Each month there is a delay in bringing critical staff on board impairs the agency's ability to fulfill this mission."
During fiscal year 2008, the FDA wants to fill more than 600 new positions and to backfill more than 700 others. That alone is nearly triple the number of people hired from 2005-2007.
The agency said qualified candidates could be on the job in as little as three weeks either in the Washington metropolitan area, or across the country in the FDA's five regions, 20 districts, more than 179 resident posts, and the newly created FDA offices overseas.
For general information and to apply for one of the positions people can submit their curriculum vitae with a cover letter via email to
joinourteam@fda.gov.
Copyright 2008 by United Press International
Related stories:
Judge: Company must give experimental drug to teen
(AP) -- A federal judge on Wednesday ordered a research company to supply an experimental drug to a 16-year-old Minnesota boy who is terminally ill with a rare form of muscular dystrophy. The decision offers no immediate relief to Jacob Gunvalson. Due to federal regulations, the teen cannot begin taking the drug immediately.
Addiction treatment proves successful in animal weight loss study
Vigabatrin, a medication proposed as a potential treatment for drug addiction by scientists at the U.S. Department of Energy's Brookhaven National Laboratory, also leads to rapid weight loss and reduced food intake according to a new animal study from the same research group. The study will be published online August 20, 2008, by the journal
Synapse. Vigabatrin is currently undergoing U.S. Food and Drug Administration (FDA)-approved Phase II clinical trials against cocaine and methamphetamine addiction across the U.S.
Mexican peppers posed problem before outbreak
(AP) -- Federal inspectors at U.S. border crossings repeatedly turned back filthy, disease-ridden shipments of peppers from Mexico in the months before a salmonella outbreak that sickened 1,400 people was finally traced to Mexican chilies.
FDA reports new deaths with diabetes drug Byetta
(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.
Lawsuits help guarantee drug safety, doctors say
(AP) -- Top doctors at the helm of one of the nation's most influential medical journals are giving the Supreme Court some unsolicited legal advice about a major case.
FDA says chemical found in plastic bottles is safe
(AP) -- Despite ongoing safety concerns from parents, consumer groups and politicians, a chemical used in baby bottles, canned food and other items is not dangerous, federal regulators said Friday.
Salmonella outbreak winds down; questions remain
(AP) -- The nationwide salmonella outbreak is finally winding down but federal health officials can't yet say how the few tainted Mexican peppers they've found could explain such widespread illness.
FDA: Some cholesterol and heart drugs don't mix
(AP) -- Patients taking some common medications for high cholesterol and irregular heart beats can suffer severe muscle damage because of a problem in the way the drugs interact, the government warned on Friday.